Filing Details

Accession Number:
0001209191-18-015303
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-01 20:48:49
Reporting Period:
2018-02-27
Accepted Time:
2018-03-01 20:48:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472187 Edi Hienrich 800 W. Olympic Blvd. Suite 406
Los Angeles CA 90015
Svp/Managing Director Emea No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-28 15,133 $79.58 45,060 No 4 M Direct
Common Stock Disposition 2018-02-28 13,077 $92.10 31,983 No 4 D Direct
Common Stock Disposition 2018-02-28 1,124 $92.10 30,859 No 4 F Direct
Common Stock Acquisiton 2018-02-28 3,359 $62.51 34,218 No 4 M Direct
Common Stock Disposition 2018-02-28 2,280 $92.10 31,938 No 4 D Direct
Common Stock Disposition 2018-02-28 590 $92.10 31,348 No 4 F Direct
Common Stock Disposition 2018-03-01 15,104 $91.61 16,244 No 4 S Direct
Common Stock Disposition 2018-03-01 8,900 $92.32 7,344 No 4 S Direct
Common Stock Disposition 2018-03-01 100 $93.06 7,244 No 4 S Direct
Common Stock Acquisiton 2018-02-27 2,936 $30.44 8,365 No 4 M Indirect By wife
Common Stock Disposition 2018-02-27 1,032 $92.10 7,333 No 4 D Indirect By wife
Common Stock Disposition 2018-02-27 958 $92.10 6,375 No 4 F Indirect By wife
Common Stock Acquisiton 2018-02-28 2,723 $79.58 9,098 No 4 M Indirect By wife
Common Stock Disposition 2018-02-28 2,353 $92.10 6,745 No 4 D Indirect By wife
Common Stock Disposition 2018-02-28 187 $92.10 6,558 No 4 F Indirect By wife
Common Stock Acquisiton 2018-02-28 655 $62.51 7,213 No 4 M Indirect By wife
Common Stock Disposition 2018-02-28 445 $92.10 6,768 No 4 D Indirect By wife
Common Stock Disposition 2018-02-28 106 $92.10 6,662 No 4 F Indirect By wife
Common Stock Disposition 2018-03-01 4,985 $92.08 1,677 No 4 S Indirect By wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Indirect By wife
No 4 D Indirect By wife
No 4 F Indirect By wife
No 4 M Indirect By wife
No 4 D Indirect By wife
No 4 F Indirect By wife
No 4 M Indirect By wife
No 4 D Indirect By wife
No 4 F Indirect By wife
No 4 S Indirect By wife
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2018-02-28 15,133 $0.00 15,133 $79.58
Common Stock Stock Appreciation Rights Disposition 2018-02-28 3,359 $0.00 3,359 $62.51
Common Stock Stock Appreciation Rights Disposition 2018-02-27 2,936 $0.00 2,936 $30.44
Common Stock Stock Appreciation Rights Disposition 2018-02-28 2,723 $0.00 2,723 $79.58
Common Stock Stock Appreciation Rights Disposition 2018-02-28 655 $0.00 655 $62.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-06-21 2023-12-19 No 4 M Direct
13,436 2017-05-09 2026-05-09 No 4 M Direct
4,404 2017-03-02 2025-03-02 No 4 M Indirect
0 2016-06-21 2023-12-19 No 4 M Indirect
2,620 2017-05-09 2026-05-09 No 4 M Indirect
Footnotes
  1. The reporting person received 932 shares of common stock upon the net exercise of 15,133 stock appreciation rights ("SARs"). The reporting person forfeited 13,077 shares of common stock underlying the SARs in payment of the exercise price and 1,124 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
  2. The reporting person received 489 shares of common stock upon the net exercise of 3,359 SARs. The reporting person forfeited 2,280 shares of common stock underlying the SARs in payment of the exercise price and 590 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
  3. This transaction includes a sale of 17,493 shares pursuant to reporting persons 10b5-1 plan.
  4. This transaction was executed in multiple trades at prices ranging from $90.92 to $91.91. The price reported reflects the weighted average sale price of $91.61. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $91.92 to $92.90. The price reported reflects the weighted average sale price of $92.32. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. The reporting person received 946 shares of common stock upon the net exercise of 2,936 SARs. The reporting person forfeited 1,032 shares of common stock underlying the SARs in payment of the exercise price and 958 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
  7. The reporting person received 183 shares of common stock upon the net exercise of 2,723 SARs. The reporting person forfeited 2,353 shares of common stock underlying the SARs in payment of the exercise price and 187 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
  8. The reporting person received 104 shares of common stock upon the net exercise of 655 SARs. The reporting person forfeited 445 shares of common stock underlying the SARs in payment of the exercise price and 106 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
  9. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  10. Consists of SARs granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested May 9, 2016 and 20% will vest May 9, 2017, and the remaining 60% will vest May 9, 2018.
  11. Consists of SARs granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on each of March 2, 2016 and March 2, 2017, and the remaining 60% will vest March 2, 2018.